#BEGIN_DRUGCARD DB03870

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H18O9

# Chemical_IUPAC_Name:
(2S,3S,4R,5S)-4-{[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}oxane-2,3,5-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Ara-Alpha(1,3)-Xyl

# HET_ID:
KHO

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H18O9/c11-1-4-5(13)6(14)10(18-4)19-8-3(12)2-17-9(16)7(8)15/h3-16H,1-2H2/t3-,4-,5-,6+,7-,8+,9-,10-/m0/s1

# InChI_Key:
InChIKey=XAQWBYJKZNCZPL-BAUARHHTSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3870

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
282.2445

# Molecular_Weight_Mono:
282.095082174

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QW8

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.9

# Predicted_LogS:
0.36

# Predicted_Water_Solubility:
6.43e+02 g/l

# Primary_Accession_No:
DB03870

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936813

# PubChem_Substance_ID:
46507065

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01971

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)CO[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:42 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AF159625

# Drug_Target_1_GenBank_ID_Protein:
16767843

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
abfA

# Drug_Target_1_Gene_Sequence:
>1509 bp
ATGGCTACGAAAAAAGCAACGATGATCATCGAAAAAGACTTCAAAATCGCTGAAATCGAC
AAACGTATTTACGGTTCTTTTATCGAGCACCTCGGCCGCGCTGTATACGGAGGGATTTAT
GAGCCGGGACATCCGCAGGCAGATGAAAACGGCTTCCGGCAAGATGTCATCGAGCTGGTC
AAAGAGCTGCAAGTGCCGATCATCCGCTATCCGGGCGGGAATTTTGTGTCCGGTTACAAC
TGGGAAGATGGAGTGGGGCCAAAAGAGCAGCGTCCGCGTCGGCTTGATTTGGCGTGGAAG
TCGGTGGAAACGAATGAAATTGGCTTGAATGAATTTATGGATTGGGCCAAGATGGTCGGA
GCTGAAGTGAATATGGCCGTCAACTTAGGGACGCGTGGCATTGATGCGGCGCGCAACTTA
GTCGAATACTGCAACCACCCGTCGGGCTCCTACTACAGCGATTTGCGCATTGCCCACGGC
TACAAAGAGCCTCATAAAATTAAAACGTGGTGCTTGGGCAATGAGATGGACGGTCCGTGG
CAAATCGGCCATAAGACGGCGGTTGAGTACGGACGAATCGCTTGTGAAGCGGCCAAAGTG
ATGAAGTGGGTCGACCCGACGATTGAACTTGTTGTGTGTGGAAGCTCAAACCGAAATATG
CCAACGTTTGCGGAATGGGAAGCGACGGTTCTTGACCATACGTATGACCATGTCGACTAT
ATTTCTCTCCATCAATACTATGGAAACCGGGACAATGATACGGCCAATTATTTGGCGTTG
TCGCTGGAAATGGATGATTTTATCCGTTCGGTTGTCGCCATCGCCGATTATGTGAAGGCG
AAAAAACGAAGCAAAAAAACGATCCACCTTTCGTTTGACGAATGGAATGTATGGTACCAC
TCGAATGAGGCAGATAAGTTAATTGAACCATGGACCGTCGCGCCGCCTCTGTTGGAAGAT
ATTTATAACTTTGAAGATGCGCTCCTTGTCGGCTGCATGCTCATTACGTTAATGAAACAT
GCGGATCGGGTGAAGATTGCTTGTTTGGCCCAATTAGTAAATGTCATTGCGCCAATCATG
ACGGAAAAGAACGGGCCGGCTTGGAAACAAACGATTTATTATCCGTTTATGCATGCATCT
GTTTATGGCAGAGGAGTGGCGTTGCATCCGGTGATTTCCAGCCCGAAATACGACAGCAAA
GACTTCACAGATGTTCCGTATTTAGAGTCGATCGCTGTTTACAATGAAGAAAAAGAAGAA
GTGACGATTTTTGCGGTCAACCGTGATATGGAAGACGCGTTGTTGTTGGAATGCGATGTT
CGCAGTTTTGAAGACTACCGTGTCATTGAACATATCGTTTTGGAACATGACAACGTGAAA
CAAACGAATTCGGCCCAATCTTCCCCGGTTGTCCCGCATCGCAACGGCGATGCCCAGCTT
TCCGATAGAAAAGTGTCGGCCACGTTGCCAAAGTTATCGTGGAACGTCATCCGTTTAGGA
AAAAGGTGA

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
7887599	Gilead S, Shoham Y: Purification and characterization of alpha-L-arabinofuranosidase from Bacillus stearothermophilus T-6. Appl Environ Microbiol. 1995 Jan;61(1):170-4.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3215

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
57213

# Drug_Target_1_Name:
Alpha-N-arabinofuranosidase

# Drug_Target_1_Number_of_Residues:
502

# Drug_Target_1_PDB_ID:
1PZ3

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF06964	Alpha-L-AF_C

# Drug_Target_1_Protein_Sequence:
>Alpha-N-arabinofuranosidase
MATKKATMIIEKDFKIAEIDKRIYGSFIEHLGRAVYGGIYEPGHPQADENGFRQDVIELV
KELQVPIIRYPGGNFVSGYNWEDGVGPKEQRPRRLDLAWKSVETNEIGLNEFMDWAKMVG
AEVNMAVNLGTRGIDAARNLVEYCNHPSGSYYSDLRIAHGYKEPHKIKTWCLGNEMDGPW
QIGHKTAVEYGRIACEAAKVMKWVDPTIELVVCGSSNRNMPTFAEWEATVLDHTYDHVDY
ISLHQYYGNRDNDTANYLALSLEMDDFIRSVVAIADYVKAKKRSKKTIHLSFDEWNVWYH
SNEADKLIEPWTVAPPLLEDIYNFEDALLVGCMLITLMKHADRVKIACLAQLVNVIAPIM
TEKNGPAWKQTIYYPFMHASVYGRGVALHPVISSPKYDSKDFTDVPYLESIAVYNEEKEE
VTIFAVNRDMEDALLLECDVRSFEDYRVIEHIVLEHDNVKQTNSAQSSPVVPHRNGDAQL
SDRKVSATLPKLSWNVIRLGKR

# Drug_Target_1_Reaction:
Hydrolysis of terminal non-reducing alpha-L-arabinofuranoside residues in alpha-L-arabinosides ALL_REAC (other) R01762 R06205(G)

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Hydrolysis of terminal non-reducing alpha-L- arabinofuranoside residues in alpha-L-arabinosides

# Drug_Target_1_SwissProt_ID:
Q9XBQ3

# Drug_Target_1_SwissProt_Name:
ABFA_GEOSE

# Drug_Target_1_Synonyms:
Arabinosidase
EC 3.2.1.55

# Drug_Target_1_Theoretical_pI:
5.72

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03870
